Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcranial Magnetic Stimulation | 57 | 2023 | 1496 | 7.900 |
Why?
|
Epilepsy | 47 | 2024 | 3320 | 4.060 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 9 | 2024 | 96 | 3.610 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 10 | 2024 | 284 | 3.530 |
Why?
|
Evoked Potentials, Motor | 16 | 2023 | 463 | 3.070 |
Why?
|
Seizures | 40 | 2024 | 3000 | 3.010 |
Why?
|
Motor Cortex | 18 | 2023 | 1003 | 2.600 |
Why?
|
Epilepsies, Partial | 10 | 2023 | 431 | 2.570 |
Why?
|
Anticonvulsants | 20 | 2024 | 1921 | 2.390 |
Why?
|
Excitatory Amino Acid Transporter 2 | 6 | 2024 | 89 | 2.290 |
Why?
|
Electroencephalography | 49 | 2024 | 6273 | 2.030 |
Why?
|
Epilepsy, Post-Traumatic | 4 | 2024 | 40 | 2.010 |
Why?
|
Sesquiterpenes | 4 | 2017 | 175 | 1.990 |
Why?
|
Alkaloids | 4 | 2017 | 190 | 1.950 |
Why?
|
Interneurons | 5 | 2024 | 593 | 1.700 |
Why?
|
gamma-Aminobutyric Acid | 9 | 2024 | 1140 | 1.620 |
Why?
|
Neural Inhibition | 5 | 2017 | 589 | 1.580 |
Why?
|
Status Epilepticus | 9 | 2023 | 460 | 1.520 |
Why?
|
Malaria, Cerebral | 2 | 2022 | 137 | 1.360 |
Why?
|
Developmental Disabilities | 10 | 2024 | 1519 | 1.330 |
Why?
|
Ceftriaxone | 5 | 2024 | 176 | 1.310 |
Why?
|
Parvalbumins | 5 | 2024 | 256 | 1.200 |
Why?
|
Cerebral Cortex | 13 | 2020 | 5767 | 1.120 |
Why?
|
Rats, Long-Evans | 13 | 2017 | 380 | 1.120 |
Why?
|
Neuronal Plasticity | 13 | 2022 | 1445 | 1.040 |
Why?
|
Glutamic Acid | 4 | 2024 | 1180 | 1.030 |
Why?
|
Long-Term Synaptic Depression | 3 | 2020 | 58 | 0.930 |
Why?
|
Excitatory Amino Acid Antagonists | 4 | 2020 | 450 | 0.890 |
Why?
|
Electric Stimulation Therapy | 5 | 2021 | 635 | 0.870 |
Why?
|
Brain Injuries | 5 | 2015 | 2060 | 0.850 |
Why?
|
Enzyme Replacement Therapy | 2 | 2021 | 80 | 0.850 |
Why?
|
Electromyography | 5 | 2020 | 1399 | 0.830 |
Why?
|
Epilepsies, Myoclonic | 1 | 2023 | 83 | 0.810 |
Why?
|
Rats | 30 | 2024 | 23707 | 0.800 |
Why?
|
Acetylcysteine | 2 | 2023 | 262 | 0.800 |
Why?
|
Cholinesterase Inhibitors | 3 | 2017 | 241 | 0.740 |
Why?
|
Angelman Syndrome | 5 | 2023 | 139 | 0.710 |
Why?
|
Early Diagnosis | 2 | 2024 | 1187 | 0.690 |
Why?
|
Animals | 73 | 2024 | 168759 | 0.680 |
Why?
|
Intracranial Hypertension | 1 | 2021 | 190 | 0.640 |
Why?
|
Epilepsia Partialis Continua | 3 | 2016 | 25 | 0.640 |
Why?
|
Language | 4 | 2022 | 1550 | 0.630 |
Why?
|
Hippocampus | 8 | 2023 | 3775 | 0.630 |
Why?
|
Electric Stimulation | 8 | 2016 | 1735 | 0.620 |
Why?
|
Functional Laterality | 6 | 2023 | 2243 | 0.610 |
Why?
|
Child | 57 | 2024 | 80563 | 0.600 |
Why?
|
Synaptic Transmission | 1 | 2024 | 1175 | 0.580 |
Why?
|
Brain | 28 | 2024 | 27178 | 0.570 |
Why?
|
Pentylenetetrazole | 5 | 2021 | 72 | 0.570 |
Why?
|
Excitatory Postsynaptic Potentials | 2 | 2016 | 366 | 0.560 |
Why?
|
Disease Models, Animal | 23 | 2024 | 18294 | 0.560 |
Why?
|
Anesthetics, Intravenous | 1 | 2020 | 397 | 0.540 |
Why?
|
Action Potentials | 6 | 2018 | 1838 | 0.510 |
Why?
|
Clinical Protocols | 1 | 2021 | 1441 | 0.500 |
Why?
|
Oxidative Stress | 4 | 2023 | 3141 | 0.500 |
Why?
|
Brain Waves | 6 | 2019 | 417 | 0.500 |
Why?
|
Pyramidal Tracts | 1 | 2017 | 249 | 0.500 |
Why?
|
Lorazepam | 1 | 2016 | 155 | 0.490 |
Why?
|
Percussion | 1 | 2014 | 17 | 0.460 |
Why?
|
Larva | 1 | 2016 | 511 | 0.460 |
Why?
|
Rats, Sprague-Dawley | 9 | 2024 | 8102 | 0.450 |
Why?
|
Spasms, Infantile | 3 | 2018 | 302 | 0.450 |
Why?
|
Propofol | 1 | 2020 | 606 | 0.440 |
Why?
|
Skull | 2 | 2009 | 811 | 0.440 |
Why?
|
Male | 91 | 2024 | 363691 | 0.440 |
Why?
|
Heart Arrest | 1 | 2024 | 1516 | 0.440 |
Why?
|
Gliosis | 2 | 2017 | 247 | 0.430 |
Why?
|
bcl-2-Associated X Protein | 1 | 2014 | 283 | 0.420 |
Why?
|
Hypothermia, Induced | 1 | 2018 | 752 | 0.420 |
Why?
|
Neurons | 9 | 2019 | 9524 | 0.410 |
Why?
|
Videotape Recording | 2 | 2011 | 331 | 0.410 |
Why?
|
Interleukin-1beta | 2 | 2016 | 1028 | 0.410 |
Why?
|
Neocortex | 1 | 2016 | 414 | 0.400 |
Why?
|
Humans | 122 | 2024 | 765956 | 0.400 |
Why?
|
Pediatrics | 7 | 2017 | 3606 | 0.400 |
Why?
|
Anesthesia | 3 | 2020 | 1590 | 0.400 |
Why?
|
Evoked Potentials, Auditory | 5 | 2016 | 530 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2014 | 576 | 0.380 |
Why?
|
Brain Concussion | 2 | 2020 | 1432 | 0.380 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 605 | 0.370 |
Why?
|
Noise | 1 | 2014 | 296 | 0.370 |
Why?
|
Heating | 1 | 2011 | 103 | 0.360 |
Why?
|
Hemispherectomy | 2 | 2022 | 40 | 0.360 |
Why?
|
Biophysical Phenomena | 1 | 2012 | 318 | 0.360 |
Why?
|
Neuroprotective Agents | 4 | 2020 | 959 | 0.360 |
Why?
|
Child, Preschool | 30 | 2024 | 42500 | 0.350 |
Why?
|
Adolescent | 42 | 2024 | 88832 | 0.350 |
Why?
|
Brain Mapping | 10 | 2022 | 6598 | 0.350 |
Why?
|
Auditory Threshold | 1 | 2012 | 369 | 0.340 |
Why?
|
Sensation Disorders | 1 | 2011 | 160 | 0.340 |
Why?
|
Orientation | 1 | 2012 | 314 | 0.340 |
Why?
|
Forelimb | 1 | 2009 | 115 | 0.330 |
Why?
|
Zebrafish | 2 | 2022 | 3035 | 0.320 |
Why?
|
Surgical Instruments | 1 | 2011 | 377 | 0.320 |
Why?
|
Critical Care | 1 | 2021 | 2712 | 0.310 |
Why?
|
Hypoxia, Brain | 2 | 2024 | 139 | 0.300 |
Why?
|
Deep Brain Stimulation | 1 | 2016 | 850 | 0.290 |
Why?
|
Brain Diseases | 3 | 2011 | 1546 | 0.280 |
Why?
|
Nervous System Diseases | 3 | 2016 | 1660 | 0.270 |
Why?
|
Placebo Effect | 1 | 2011 | 514 | 0.270 |
Why?
|
GABA Agents | 2 | 2020 | 40 | 0.270 |
Why?
|
Infant | 20 | 2024 | 36385 | 0.260 |
Why?
|
Bone Plates | 1 | 2009 | 469 | 0.260 |
Why?
|
Memory | 5 | 2017 | 2190 | 0.260 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2971 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2023 | 2056 | 0.250 |
Why?
|
Mice, Inbred C57BL | 10 | 2024 | 22331 | 0.250 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 2017 | 896 | 0.250 |
Why?
|
Female | 65 | 2024 | 396101 | 0.250 |
Why?
|
Mice | 21 | 2024 | 81818 | 0.250 |
Why?
|
Space Perception | 2 | 2000 | 469 | 0.250 |
Why?
|
Tuberous Sclerosis | 3 | 2023 | 1038 | 0.240 |
Why?
|
Sleep | 8 | 2023 | 4812 | 0.240 |
Why?
|
Oxidopamine | 3 | 2021 | 168 | 0.240 |
Why?
|
Axons | 2 | 2015 | 1682 | 0.240 |
Why?
|
Titanium | 1 | 2007 | 490 | 0.230 |
Why?
|
Dizocilpine Maleate | 2 | 2014 | 171 | 0.220 |
Why?
|
Fragile X Syndrome | 2 | 2016 | 116 | 0.220 |
Why?
|
Convulsants | 2 | 2021 | 70 | 0.220 |
Why?
|
Long-Term Potentiation | 3 | 2017 | 290 | 0.220 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2023 | 38 | 0.220 |
Why?
|
Immunotherapy | 2 | 2021 | 4752 | 0.220 |
Why?
|
Young Adult | 25 | 2024 | 59886 | 0.220 |
Why?
|
ARNTL Transcription Factors | 1 | 2023 | 98 | 0.210 |
Why?
|
Kainic Acid | 2 | 2016 | 204 | 0.200 |
Why?
|
Sodium Oxybate | 1 | 2023 | 36 | 0.200 |
Why?
|
Muscle, Skeletal | 3 | 2023 | 4959 | 0.200 |
Why?
|
Education, Medical | 2 | 2011 | 1746 | 0.200 |
Why?
|
Triazoles | 3 | 2014 | 897 | 0.200 |
Why?
|
Treatment Outcome | 22 | 2022 | 65189 | 0.200 |
Why?
|
Pyramidal Cells | 2 | 2003 | 365 | 0.190 |
Why?
|
Epilepsy, Absence | 1 | 2022 | 50 | 0.190 |
Why?
|
Theta Rhythm | 2 | 2021 | 220 | 0.190 |
Why?
|
Diazepam | 2 | 2013 | 215 | 0.190 |
Why?
|
Intracranial Aneurysm | 1 | 2011 | 1272 | 0.190 |
Why?
|
Mental Disorders | 3 | 2016 | 6851 | 0.190 |
Why?
|
Zambia | 1 | 2022 | 273 | 0.190 |
Why?
|
Parkinson Disease, Secondary | 1 | 2021 | 118 | 0.190 |
Why?
|
Circadian Clocks | 1 | 2023 | 168 | 0.190 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8728 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7478 | 0.180 |
Why?
|
Behavior, Animal | 7 | 2017 | 1865 | 0.180 |
Why?
|
Learning | 2 | 2020 | 1755 | 0.180 |
Why?
|
Dementia, Vascular | 1 | 2021 | 126 | 0.170 |
Why?
|
Phenytoin | 1 | 2020 | 189 | 0.160 |
Why?
|
Osteochondrodysplasias | 1 | 2021 | 183 | 0.160 |
Why?
|
Evaluation Studies as Topic | 1 | 2021 | 1600 | 0.160 |
Why?
|
Nerve Net | 1 | 2011 | 2310 | 0.160 |
Why?
|
Epilepsy, Rolandic | 1 | 2020 | 57 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36532 | 0.160 |
Why?
|
Gait | 2 | 2021 | 820 | 0.160 |
Why?
|
Parkinsonian Disorders | 2 | 2020 | 286 | 0.160 |
Why?
|
Calcium Channels, R-Type | 1 | 2018 | 13 | 0.160 |
Why?
|
Electrodes | 3 | 2012 | 609 | 0.150 |
Why?
|
Motor Skills | 1 | 2021 | 516 | 0.150 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2020 | 276 | 0.150 |
Why?
|
Benzocycloheptenes | 1 | 2018 | 6 | 0.150 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 484 | 0.150 |
Why?
|
Social Isolation | 1 | 2021 | 366 | 0.150 |
Why?
|
Hand | 1 | 2023 | 909 | 0.150 |
Why?
|
Dyskinesias | 1 | 2018 | 79 | 0.150 |
Why?
|
GABA Antagonists | 1 | 2018 | 120 | 0.150 |
Why?
|
Depressive Disorder | 2 | 2023 | 3710 | 0.150 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
Aging | 3 | 2019 | 8731 | 0.140 |
Why?
|
Drug Therapy, Combination | 3 | 2024 | 6309 | 0.140 |
Why?
|
Telemetry | 1 | 2018 | 201 | 0.140 |
Why?
|
Retrospective Studies | 20 | 2023 | 81515 | 0.140 |
Why?
|
Reaction Time | 1 | 2023 | 2086 | 0.140 |
Why?
|
Equipment Design | 2 | 2016 | 3481 | 0.140 |
Why?
|
Adult | 21 | 2022 | 223038 | 0.140 |
Why?
|
Acetylcholinesterase | 1 | 2016 | 150 | 0.130 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2016 | 57 | 0.130 |
Why?
|
Levodopa | 1 | 2017 | 222 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 2019 | 183 | 0.130 |
Why?
|
Bicuculline | 1 | 2016 | 94 | 0.130 |
Why?
|
Models, Animal | 3 | 2016 | 2120 | 0.130 |
Why?
|
Autistic Disorder | 2 | 2017 | 1239 | 0.130 |
Why?
|
Memantine | 1 | 2017 | 110 | 0.130 |
Why?
|
Cycloheximide | 1 | 2016 | 339 | 0.130 |
Why?
|
Pain | 1 | 2011 | 5077 | 0.130 |
Why?
|
Contracture | 1 | 2018 | 234 | 0.130 |
Why?
|
Cation Transport Proteins | 1 | 2018 | 325 | 0.130 |
Why?
|
Rare Diseases | 1 | 2021 | 635 | 0.130 |
Why?
|
Individuality | 1 | 2017 | 303 | 0.130 |
Why?
|
Malformations of Cortical Development | 1 | 2017 | 174 | 0.130 |
Why?
|
Acoustics | 2 | 2014 | 235 | 0.120 |
Why?
|
Wakefulness | 3 | 2018 | 1282 | 0.120 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 490 | 0.120 |
Why?
|
Microelectrodes | 1 | 2016 | 304 | 0.120 |
Why?
|
Synaptosomes | 1 | 2015 | 116 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2022 | 5302 | 0.120 |
Why?
|
Prospective Studies | 8 | 2024 | 54806 | 0.120 |
Why?
|
Animals, Newborn | 4 | 2015 | 2669 | 0.120 |
Why?
|
Neurophysiology | 1 | 2015 | 145 | 0.120 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9550 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 465 | 0.120 |
Why?
|
Receptors, Glutamate | 1 | 2015 | 227 | 0.110 |
Why?
|
Electrophysiological Phenomena | 1 | 2016 | 307 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2015 | 6203 | 0.110 |
Why?
|
United States Occupational Safety and Health Administration | 1 | 2014 | 54 | 0.110 |
Why?
|
Fluoresceins | 1 | 2014 | 234 | 0.110 |
Why?
|
Imidazoles | 2 | 2017 | 1162 | 0.110 |
Why?
|
Tourette Syndrome | 1 | 2017 | 400 | 0.110 |
Why?
|
Genetic Variation | 2 | 2019 | 6610 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4392 | 0.110 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7875 | 0.110 |
Why?
|
Species Specificity | 2 | 2021 | 2406 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 969 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10729 | 0.110 |
Why?
|
Sirolimus | 2 | 2020 | 1545 | 0.100 |
Why?
|
Receptors, GABA | 1 | 2015 | 312 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2014 | 610 | 0.100 |
Why?
|
Temperature | 2 | 2011 | 2226 | 0.100 |
Why?
|
Schizophrenia | 3 | 2016 | 6971 | 0.100 |
Why?
|
Pilot Projects | 3 | 2021 | 8733 | 0.100 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2019 | 884 | 0.100 |
Why?
|
Bumetanide | 1 | 2013 | 101 | 0.100 |
Why?
|
Computer Simulation | 2 | 2016 | 6255 | 0.100 |
Why?
|
Suicide | 1 | 2023 | 1604 | 0.100 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2012 | 54 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1883 | 0.100 |
Why?
|
Phenobarbital | 1 | 2013 | 192 | 0.100 |
Why?
|
Cerebral Palsy | 1 | 2017 | 481 | 0.100 |
Why?
|
Substantia Nigra | 1 | 2014 | 346 | 0.100 |
Why?
|
Chromium Alloys | 1 | 2011 | 71 | 0.100 |
Why?
|
Antioxidants | 1 | 2020 | 1670 | 0.100 |
Why?
|
Sound | 1 | 2014 | 257 | 0.100 |
Why?
|
Animals, Genetically Modified | 1 | 2016 | 1560 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.100 |
Why?
|
Visual Perception | 2 | 2014 | 1394 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1087 | 0.090 |
Why?
|
Neurosciences | 1 | 2016 | 385 | 0.090 |
Why?
|
Cerebral Ventricles | 1 | 2014 | 549 | 0.090 |
Why?
|
Tauopathies | 1 | 2015 | 325 | 0.090 |
Why?
|
Language Development Disorders | 1 | 2013 | 194 | 0.090 |
Why?
|
Electrodes, Implanted | 3 | 2020 | 830 | 0.090 |
Why?
|
Research Design | 3 | 2021 | 6208 | 0.090 |
Why?
|
Pentobarbital | 1 | 2011 | 153 | 0.090 |
Why?
|
Disease Progression | 3 | 2017 | 13631 | 0.090 |
Why?
|
Behavior | 1 | 2014 | 535 | 0.090 |
Why?
|
Brain Neoplasms | 3 | 2022 | 9071 | 0.090 |
Why?
|
Magnetics | 1 | 2014 | 585 | 0.090 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 3718 | 0.090 |
Why?
|
Astrocytes | 2 | 2017 | 1345 | 0.090 |
Why?
|
Leukomalacia, Periventricular | 1 | 2012 | 184 | 0.090 |
Why?
|
Time Factors | 11 | 2020 | 40065 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1587 | 0.090 |
Why?
|
Rats, Wistar | 3 | 2021 | 1884 | 0.090 |
Why?
|
Phosphorylation | 2 | 2023 | 8278 | 0.090 |
Why?
|
Benzamides | 1 | 2016 | 1377 | 0.090 |
Why?
|
Biophysics | 1 | 2012 | 375 | 0.090 |
Why?
|
Acoustic Stimulation | 4 | 2016 | 1255 | 0.090 |
Why?
|
Uniparental Disomy | 1 | 2010 | 46 | 0.090 |
Why?
|
Vagus Nerve Stimulation | 1 | 2013 | 228 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2015 | 597 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.080 |
Why?
|
Mice, 129 Strain | 2 | 2021 | 369 | 0.080 |
Why?
|
Piracetam | 1 | 2010 | 88 | 0.080 |
Why?
|
Acetamides | 1 | 2011 | 260 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2015 | 1325 | 0.080 |
Why?
|
Language Tests | 3 | 2014 | 191 | 0.080 |
Why?
|
Cats | 1 | 2010 | 972 | 0.080 |
Why?
|
tau Proteins | 2 | 2021 | 2112 | 0.080 |
Why?
|
Efferent Pathways | 1 | 2009 | 164 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1308 | 0.080 |
Why?
|
Trisomy | 1 | 2010 | 259 | 0.080 |
Why?
|
Critical Illness | 1 | 2021 | 2744 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2968 | 0.080 |
Why?
|
Risk Factors | 6 | 2023 | 74836 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14652 | 0.080 |
Why?
|
Membrane Potentials | 1 | 2012 | 1083 | 0.080 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 451 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2888 | 0.070 |
Why?
|
Protein Binding | 1 | 2020 | 9296 | 0.070 |
Why?
|
Risk | 2 | 2016 | 9591 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2014 | 1136 | 0.070 |
Why?
|
Electric Impedance | 1 | 2012 | 794 | 0.070 |
Why?
|
Receptors, GABA-A | 1 | 2011 | 624 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7584 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2023 | 2590 | 0.070 |
Why?
|
Anesthesia, General | 1 | 2014 | 1172 | 0.070 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2008 | 869 | 0.070 |
Why?
|
Mosaicism | 1 | 2010 | 481 | 0.070 |
Why?
|
Synapses | 2 | 2012 | 1754 | 0.070 |
Why?
|
Internal Fixators | 1 | 2007 | 183 | 0.070 |
Why?
|
Hearing Loss | 1 | 2014 | 784 | 0.070 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2017 | 179 | 0.070 |
Why?
|
Glioma | 1 | 2021 | 3493 | 0.070 |
Why?
|
Infant, Newborn | 6 | 2021 | 26349 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18380 | 0.060 |
Why?
|
Forecasting | 2 | 2014 | 2936 | 0.060 |
Why?
|
Pyrazoles | 1 | 2016 | 2033 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2013 | 1456 | 0.060 |
Why?
|
Thalamus | 1 | 2012 | 1048 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 8067 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8041 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4348 | 0.060 |
Why?
|
Mice, Knockout | 5 | 2019 | 14447 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 2 | 2023 | 2796 | 0.060 |
Why?
|
Mice, Inbred CBA | 2 | 2021 | 439 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1880 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39194 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2009 | 1206 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 355 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3432 | 0.060 |
Why?
|
Stroke | 3 | 2020 | 9747 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8529 | 0.060 |
Why?
|
Evoked Potentials | 3 | 2016 | 1048 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 441 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2692 | 0.060 |
Why?
|
Homeostasis | 1 | 2015 | 3336 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7232 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2014 | 1805 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4808 | 0.050 |
Why?
|
Neural Pathways | 2 | 2012 | 3087 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2016 | 3895 | 0.050 |
Why?
|
Pilocarpine | 1 | 2023 | 64 | 0.050 |
Why?
|
Statistics, Nonparametric | 3 | 2014 | 2845 | 0.050 |
Why?
|
Aquaporin 4 | 1 | 2023 | 161 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2015 | 12769 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3967 | 0.050 |
Why?
|
COS Cells | 1 | 2024 | 1136 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9601 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4668 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1792 | 0.050 |
Why?
|
Lewy Body Disease | 1 | 2024 | 255 | 0.050 |
Why?
|
Laryngostenosis | 1 | 2023 | 168 | 0.050 |
Why?
|
Frontotemporal Dementia | 1 | 2024 | 248 | 0.050 |
Why?
|
Age of Onset | 3 | 2014 | 3343 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 223004 | 0.050 |
Why?
|
Phenotype | 4 | 2023 | 16721 | 0.050 |
Why?
|
Fructose | 1 | 2023 | 286 | 0.040 |
Why?
|
Appetitive Behavior | 1 | 2000 | 39 | 0.040 |
Why?
|
Prevalence | 2 | 2023 | 15839 | 0.040 |
Why?
|
Neuronavigation | 1 | 2022 | 167 | 0.040 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2021 | 365 | 0.040 |
Why?
|
Spatial Behavior | 1 | 2000 | 88 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7599 | 0.040 |
Why?
|
Dibenzazepines | 1 | 2020 | 26 | 0.040 |
Why?
|
Maze Learning | 2 | 2017 | 482 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12131 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2022 | 551 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2013 | 3800 | 0.040 |
Why?
|
Sonication | 1 | 2020 | 78 | 0.040 |
Why?
|
Neurology | 1 | 2007 | 785 | 0.040 |
Why?
|
Receptors, AMPA | 1 | 2021 | 334 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2012 | 1732 | 0.040 |
Why?
|
Vigabatrin | 1 | 2020 | 88 | 0.040 |
Why?
|
Pyrrolidinones | 1 | 2020 | 116 | 0.040 |
Why?
|
Beta Rhythm | 1 | 2019 | 65 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.040 |
Why?
|
Delta Rhythm | 1 | 2019 | 81 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9249 | 0.040 |
Why?
|
Losartan | 1 | 2020 | 263 | 0.040 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2017 | 26 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 30258 | 0.040 |
Why?
|
Risk Assessment | 2 | 2011 | 24283 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2020 | 246 | 0.040 |
Why?
|
Grooming | 1 | 2017 | 39 | 0.040 |
Why?
|
Cadherins | 1 | 2022 | 900 | 0.040 |
Why?
|
Serum Albumin | 1 | 2020 | 675 | 0.030 |
Why?
|
Isoflurane | 1 | 2020 | 384 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15398 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10563 | 0.030 |
Why?
|
Motor Activity | 2 | 2017 | 2704 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2017 | 425 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1210 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2017 | 286 | 0.030 |
Why?
|
Homozygote | 1 | 2021 | 1775 | 0.030 |
Why?
|
Genotype | 2 | 2021 | 13024 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2021 | 1218 | 0.030 |
Why?
|
Erythropoietin | 1 | 2020 | 716 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2015 | 222 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3458 | 0.030 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1087 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2017 | 564 | 0.030 |
Why?
|
Vocalization, Animal | 1 | 2015 | 95 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2015 | 251 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3202 | 0.030 |
Why?
|
Ultrasonics | 1 | 2015 | 209 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3672 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1037 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2023 | 1461 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2013 | 56 | 0.030 |
Why?
|
Algorithms | 3 | 2022 | 14071 | 0.030 |
Why?
|
Presynaptic Terminals | 1 | 2015 | 297 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2015 | 345 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7122 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 951 | 0.020 |
Why?
|
CA1 Region, Hippocampal | 1 | 2013 | 110 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2016 | 22222 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1624 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1458 | 0.020 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2013 | 157 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10850 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 569 | 0.020 |
Why?
|
Liposomes | 1 | 2015 | 788 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 647 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2832 | 0.020 |
Why?
|
Cognition | 2 | 2020 | 7048 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1874 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2019 | 1477 | 0.020 |
Why?
|
Symporters | 1 | 2013 | 362 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4258 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1432 | 0.020 |
Why?
|
Dementia | 1 | 2024 | 2744 | 0.020 |
Why?
|
Auditory Perception | 1 | 2014 | 587 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2207 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1749 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2523 | 0.020 |
Why?
|
Child Psychiatry | 1 | 2011 | 231 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 777 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2794 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1372 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1402 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20125 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15880 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1377 | 0.020 |
Why?
|
Cell Death | 1 | 2013 | 1679 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13400 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10602 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.020 |
Why?
|
Magnetoencephalography | 1 | 2011 | 585 | 0.020 |
Why?
|
Intelligence | 1 | 2012 | 923 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2007 | 265 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9338 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7425 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2446 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2013 | 14749 | 0.020 |
Why?
|
Safety | 1 | 2011 | 1157 | 0.020 |
Why?
|
Aged | 3 | 2021 | 171114 | 0.020 |
Why?
|
United States | 1 | 2014 | 72898 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4908 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5876 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 1892 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6014 | 0.020 |
Why?
|
Drug Resistance | 1 | 2011 | 1591 | 0.020 |
Why?
|
Polysomnography | 1 | 2012 | 1859 | 0.020 |
Why?
|
Signal Transduction | 2 | 2018 | 23600 | 0.010 |
Why?
|
Calcium | 1 | 2017 | 5767 | 0.010 |
Why?
|
Body Weight | 1 | 2015 | 4622 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2010 | 12976 | 0.010 |
Why?
|
Mossy Fibers, Hippocampal | 1 | 2003 | 29 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6897 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8701 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12437 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18973 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3561 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41647 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16047 | 0.010 |
Why?
|
Dogs | 1 | 2006 | 3822 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4034 | 0.010 |
Why?
|
Premature Birth | 1 | 2012 | 1829 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13266 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30196 | 0.010 |
Why?
|
Recovery of Function | 1 | 2007 | 2966 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 8927 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10383 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12795 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 13461 | 0.010 |
Why?
|
Internship and Residency | 1 | 2010 | 5946 | 0.010 |
Why?
|